한약재 물 추출물의 생리활성 검색 및 MPTP-유도 신경독성에 대한 대황의 보호효과

참고문헌 (113)

1. "Prevalence of Alzheimer' disease in community population of older persons", pp.2551~262 2556 (1989)
2. "National Institute on Aging Progress Report on Alzheimer's disease", pp.~3994 (1995)
3. "Diagnosis of Alzheimer's disease", pp.1097~1105 (1985)
4. "The prevalence of dementia A quantitative integration of the literature", pp.564~479 (1987)
5. "Neuroprotective therapy for Parkinson's disease", pp.24~28 (1997)
6. "Role of free radicals and catalytic metal ions in human disease Methods in Enzymology 186", pp.1~85 (1990)
7. "Metal ion-catalyzed oxidation of proteins", pp.315~325 (1990)
8. "free radical production in neural degeneration", pp.37~63 122 (1994)
9. "Oxidative damage to DNA in diabetes mellitus", pp.444~347 445 (1996)
10. "Evidence fro neuronal oxidative damage in Alzheimer's disease", ola(w), pp.21~28 (1996)
11. "A simple screening method for antioxidants and isolation of several antioxidants produced by marine bacteria from fish and shellfish", pp.1780~1783 (1994)
12. "Oxidative stress and genetics in the pathogenesis of Parkinsons disease", pp.240~7 250 (2000)
13. "Toxicology and biochemistry of butylated hydroxyanisole and butylated hydroxytoluene", pp.59~63 (1975)
14. "health protection branch studies on butylated hydroxyanisole", phe(lic antioxidants), pp.49~54 (1995)
15. "Pharmacological treatment of cognitive deficits in Azheimer's disease", pp.324~329 (2001)
16. "Cholinesterase in cerebrosponal fluid A longitudinal study in Alzheimer disease", pp.403~407 (1987)
17. "A disorder of cortical cholinergic innervation", pp.1184~219 1189 (1983)
18. "Acetylcholinesterase in Alzheimer's disease" (1961)
19. "Possible causes of Alzheimer's disease", pp.129~5 141 (1998)
20. "Cognitive enhancement therapy for Alzheimer's disease", pp.752~53 768 (1997)
21. "Acetylcholinesterase inhibition by territrem B derivatives", pp.857~862 (1995)
22. "An acetylcholinesterase inhibitor isolated from Corydalis Tuber and its mode of action", pp.91~95 (1996)
23. "Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia", pp.170~178 (1997)
24. "Inhibition of nitric oxide synthase by 1-", anti(ciceptive and cardiovascular effects), pp.2 423~431 (1996)
25. "Monoamine oxidase B in brains from patients with Alzheimer's disease", pp.1~12 (1991)
26. "The molecular pharmacology of L-deprenyl", pp.97~108 (1992)
27. "Purification and properties of human brain mitochondrial monoamine oxidase", pp.15~39 25 (1970)
28. "Qualitative and quantitative evaluation of anthraquinone derivaties in Indian rhubarb", pp.103~108 (1972)
29. "Substrate and inhibitor- related characteristics of human platelet monoamine oxidase", pp.853~858 (1977)
30. "The monoamine oxidases of brain selective inhibition with drugs and the consequences for the metabolism of the biogenic amines", pp.733~740 (1974)
31. "MPTP mechanism of neurotoxicity and their implications for Parkinson's disease", pp.273~286 (1991)
32. "Chronic parkinsonism in human due to a product of meperidine analog synthesis", pp.979~219 980 (1983)
33. "The neurotoxicity of 1-methyl-4-phenyl-1 6- tetrahydropyridine in the monkey and man", pp.166~168 (1984)
34. "Metabolism of the neurotoxic tertiary amine", and castag(li), pp.574~578 (1984)
35. "Intraneuronal generation of a pyridinium metabolic may cause drug-induced parkinsonism", pp.464~311 467 (1984)
36. "The role of oxidative stress in the systematic toxicity of MPTP and MPP+", pp.571~574 (1986), Academic Press New York
37. "MPP+ and MPDP+ induced oxygen radical formation with mitochondrial enzymes"
38. "evidence from measures of reactive oxygen species dopamine levels", pp.27~18 34 (1994)
39. "Evidence for generation of oxidative stress in brain by MPTP in vitro and in vivo studies in mice", pp.44~52 (1997)
40. "Oxidative stress induced by MPTP and MPP+ selective vulnerability of cultured astrocytes", pp.237~244 (1999)
41. "The specific vulmerability of the substantia nigra to MPTP is related to the presence of transition metals", pp.25~33 (1985)
42. "Effect of MPTP and L-Deprenyl on antioxidants enzymes and lipid peroxidation level in mouse brain", pp.2725~2733 (1995)
43. "Rapid ATP loss caused by 1-methyl-4-phenyl-1 6-tetrahydropyridine in mouse brain", pp.348~351 (1991)
44. "Inhibition of mitochondrial NADH dehydrogenase by pyridine derivaties and its possible relation to experimental and idophathic Parkinsonism", pp.267~275 (1986)
45. "Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridinium a metabolite of the neurotoxine", pp.1 6 2503~2508 (1985)
46. "Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridinium ion", pp.294~299 (1987)
47. "Selective accumulation of MPP+ in the substantia nigra a key to neurotoxicity", pp.207~212 (1985)
48. "6-tetrahydropyridine is neurotoxic to the nigro-striatal dopamine pathway", pp.1 56~319 57 (1986)
49. "Resistance of golden hamster to 1-methyl-4-phenyl-1 relationship with low levels of regional monoamine oxidase-B", pp.6~ (1906)
50. "Neuroprotective strategies for basal ganglia degeneration Progress in Neurobiology 60", pp.409~470 (2000)
51. "Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenyl- 1" (1951)
52. "MPTP parkinsonism in humans and animals", pp.137~144 (1987)
53. "Oxidation products arising from the action of monoamine oxidase B on 1-methyl-4-benzyl-1 A nonneurotoxic analogue of 1-methyl-4-phenyl-1", pp.6 6 2012~2016 (1994)
54. "Apomorphine protects against MPTP-induced neurotoxicity in mice", pp.612~618 (1999)
55. "Protection against the dopaminergic neurotoxicity of 1- methyl- 4- phenyl- 1 6 -tetrahydropyridine by monoamine oxidase inhibitor", manzi, pp.467~311 469 (1984)
56. "Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1", pp.6 209~210 (1984)
57. "Selegiline is neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridinium"
58. "-deprenyl of 1-methyl-4-phenylpyridinium ion -induced apotosis independent of MAO-B inhibition"
59. "The effects of L-deprenyl treatment alone and combined with GM1 ganglioside", pp.226~230 (1998), on striatal dopamine content and substantia nigra pars compacta neurons
60. "6-tetrahydropyridine induced ATP loss in the mouse striatum", pp.7 41~48 (1999)
61. "multiple roles in the therapy of neurodegenerative disorders", pp.25~47 (2000)
62. "The protective of riluzole in the MPTP model of Parkinson's disease in mice is not due to in MPP+ accumulation", pp.1016~1020 (2000)
63. "Biological effects of the superoxide radical", pp.1~15 (1986)
64. "Historical introduction to free radical and antioxidant biomedical research In CRC handbook of free radical and antioxidants in biomedicine", pp.3~16 (1989), CRC Press
65. "Oxidative processes and antioxidative defense mechanism in the aging brain", pp.526~533 (1995)
66. "Brief communication azulenyl nitrone spin trap protect against MPTP neurotoxicity", pp.163~166 (1998)
67. "Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice", pp.157~164 (1999)
68. "Neuroprotection by sodium salicylate against 1-methyl- 4-phenyl-1", pp.6 281~290 (2000)
69. "Monoamine oxidase_B inhibitors in treatment Alzheimers disease", pp.343~348 (2000)
70. "Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1 6- tetrahydropyridine in C57BL", 6 mice, 167~281 170
71. "Elevation of antioxidant potency in the brain of mice by low-dose γ-ray irradiation and its effect on 1-methyl-4-phenyl-1", pp.6 388~395 (1999)
72. "Total antioxidant status in plasma and body fluids", pp.279~293 (1994)
73. "Serum lipoperoxide levels in patients suffering from liver disease", pp.267~270 (1977)
74. "Correlation of 1-methyl-4-phenyl-1 6-tetrahydropyridine neurotoxicity with blood brain barrier monoamine oxidase activity", pp.3521~3525 (1987)
75. "Protein measurment with the Folin-phenol reagent", pp.265~275 (1951)
76. "Organic hydroperoxide-induced lipid peroxidation and cell death in isolated hepatocytes", pp.78 473~483 (1985)
77. "Age- and peroxidative stress- related modifications of the cerebral enzymatic activities linked to mitochondria and glutathione system", pp.77~101 (1995)
78. "Are reative oxygen species involved in Alzheimer's disease", pp.661~16 671 (1995)
79. "Relationship of resistance to oxygen free radicals to CuZn-superoxide dismutase activity in trasgenic", pp.903~910
80. "Shortcomings of an automated assay for total antioxidant status in biological fluids", pp.1712~1714 (1996)
81. "Analytical aspects of antioxidants and free radical activity in clinical biochemistry"
82. "Annals of Clinical Biochemistry 35", pp.48~56 (1998)
83. "Comparative antioxidant potential of anaethetics and perioperative drugs in vitro Comparison of relative antioxidant activities of British medicinal plant species in vitro", eth(pharmacol), pp.41 47~53 51 (2000), Clinica Chimica Acta 301
84. "Hydroxyl radical scavenging activity of flavonoids", pp.2489~2491 (1987)
85. "Age- related changes in reactive oxygen species production in rat brain homogenates", pp.175~22 181 (2000)
86. "Effective human cancer prevention as goal for the regulation of environmental chemicals", pp.339~351 (1991)
87. "The contribution of plant food antioxidants to human health", pp.75~6 82 (1995)
88. "Journal of Cereal Science 33", pp.115~129 (2001)
89. "三和散이 腦組織의 acetylcholine esterase 및 monoamine oxidase 活性에 미치는 影響", pp.78~92 (1997)
90. "七福飮이 노화 백서 뇌조직의 생화학적 변화에 미치는 영향", pp.25~37 (1997)
91. "定志丸이 腦組織의 生化學的 變化와 神經細胞의 損傷에 미치는 實驗的 硏究", pp.392~409 (1998)
92. "Monoamine oxidase activity and monoamine metabolism in brains of Parkinsonianpatients treated with L-deprenyl", pp.1359~1365 (1986)
93. "The concurrent estimation of the major monoamine metabolites in human and non-human primate brain by HPLC with fluorescence and electrochemical detection", pp.499~505 (1981)
94. "Quinoline and quinaldine as naturally occurring inhibitors specific for type A monoamine oxidase", pp.1075~1082 (1986)
95. "Screening of unsubstituted cyclic compounds as inhibitors of monoamine oxidases", pp.2307~2310 (1994)
96. "Isolation of monoamine oxidase B inhibitory compound from the leaves of Eucommia ulmoides", pp.166~169 (1999)
97. "Phenolics with inhibitory activity on mouse brain monoamine oxidase from whole parts of Artemisia vulgaris L", pp.179~182 (2000)
98. "Screening of the acetylcholinesterase inhibitors from medicinal plants", pp.167~173 (1997)
99. "Kinetic evaluation of MAO-B activity following oral administration of selegiline and desmethyl-selegiline in the rat", pp.131~137 (1990)
100. "Pargyline-induced mania in primary affective disorder", pp.25~44 26 (1983)
101. "Spontaneaus blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys", pp.214~158 220 (1999)
102. "Comparative toxicity of MPTP 3- dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra", iacofa, pp.3 171~174 (1986)
103. "MK-81 fail to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1 6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridium in rats", manzi (1979)
104. "Difference in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1 6-tetrahydropyridine in C57", BL and CD-1 mice, 195-2041994, ~126
105. "No changes in behavior nigro-striatal system neurochemistry or neuronal cell death following toxic multiple oral paraquat administration to rats", pp.583~591 (1996)
106. "Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo", pp.351~359 (1998)
107. "Mechanism of food restriction Protection of cellular homeostasis", pp.13~15 (1990)
108. "MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways", pp.76~84 (1998)
109. "in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake", and castag(ll), pp.1 65~74 (1989)
110. "The neurotoxicity and the relevance to Parkonson's disease", pp.8~13 (1990)
111. "Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4- phenyl-1", castag and castag(li li), pp.6 856~864 (1999)
112. "In advances in neurology", pp.499~510 (1979), Ravan Press
113. "In Treatment of Depression", pp.237~252 (1983), Raven Press

관련 논문AI추천